Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-295065
Filing Date
2013-07-19
Accepted
2013-07-19 09:33:45
Documents
12
Period of Report
2013-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d569072d6k.htm 6-K 10456
2 EX-99.1 d569072dex991.htm EX-99.1 44665
3 GRAPHIC g569072ex99_1pg01.jpg GRAPHIC 164471
4 GRAPHIC g569072ex99_1pg02.jpg GRAPHIC 42401
5 GRAPHIC g569072ex99_1pg03.jpg GRAPHIC 97367
6 GRAPHIC g569072ex99_1pg04.jpg GRAPHIC 100142
7 GRAPHIC g569072ex99_1pg05.jpg GRAPHIC 92125
8 GRAPHIC g569072ex99_1pg06.jpg GRAPHIC 107819
9 GRAPHIC g569072ex99_1pg07.jpg GRAPHIC 83059
10 GRAPHIC g569072ex99_1pg08.jpg GRAPHIC 81301
11 GRAPHIC g569072ex99_1pg09.jpg GRAPHIC 75601
12 GRAPHIC g569072ex99_1pg10.jpg GRAPHIC 128827
  Complete submission text file 0001193125-13-295065.txt   1398392
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 13976015
SIC: 2834 Pharmaceutical Preparations